Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Eur J Cancer Care (Engl) ; 24(1): 111-6, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-24304429

RESUMO

This study retrospectively investigated the clinical features and risk factors of allergic reactions induced by oxaliplatin administration. This study investigated the incidence of allergic reactions and analysed the background and laboratory data in patients with colorectal cancer treated with oxaliplatin-based chemotherapy at Kyushu Medical Center between April 2012 and September 2012. A total of 62 patients were included in this study. The number of patients in the allergic and non-allergic groups was 7 and 55 respectively. The incidence of allergic reactions was 11.3%. We compared the patients' characteristics and laboratory data between the two groups and found that the average dose of dexamethasone in the allergic group was significantly lower than that observed in the non-allergic group (P = 0.0111). Furthermore, the incidence of allergic reactions in the group that received prophylaxis of less than 12 mg of dexamethasone was significantly higher than that observed in the group that received more than 12 mg of dexamethasone (P = 0.0103). In conclusion, a lower dexamethasone dose is a possible risk factor for allergic reactions induced by the administration of oxaliplatin; however, given the retrospective design used in this study, further validation of this finding is warranted.


Assuntos
Antineoplásicos/efeitos adversos , Neoplasias Colorretais/tratamento farmacológico , Hipersensibilidade a Drogas/epidemiologia , Compostos Organoplatínicos/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Antineoplásicos/administração & dosagem , Neoplasias Colorretais/sangue , Dexametasona/administração & dosagem , Hipersensibilidade a Drogas/etiologia , Hipersensibilidade a Drogas/prevenção & controle , Feminino , Glucocorticoides/administração & dosagem , Humanos , Incidência , Japão/epidemiologia , Masculino , Pessoa de Meia-Idade , Compostos Organoplatínicos/administração & dosagem , Oxaliplatina , Estudos Retrospectivos , Fatores de Risco
2.
Intern Med ; 32(7): 540-2, 1993 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-8286830

RESUMO

A rare case of protothecosis in a 40-year-old Japanese woman with systemic lupus erythematosus, under long-term prednisolone treatment is presented. The patient developed extensive ulcerative skin lesions after injury. The characteristic histopathological findings and biochemical sugar assimilation tests indicated infection by Prototheca wicherhamii. The lesions improved following treatment with amphotericin B. The immunodeficient state of this patient seemed to contribute to the infection with Prototheca.


Assuntos
Lúpus Eritematoso Sistêmico/complicações , Prototheca , Dermatopatias Infecciosas/microbiologia , Abscesso/complicações , Abscesso/microbiologia , Adulto , Anfotericina B/uso terapêutico , Feminino , Humanos , Imunidade Celular , Hospedeiro Imunocomprometido , Infecções , Lúpus Eritematoso Sistêmico/tratamento farmacológico , Prednisolona/efeitos adversos , Prednisolona/uso terapêutico , Dermatopatias Infecciosas/complicações , Dermatopatias Infecciosas/tratamento farmacológico , Úlcera Cutânea/complicações , Úlcera Cutânea/microbiologia , Lesões no Cotovelo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA